throbber
GASTROENTEROLOGY 2008;135:499 –507
`
`ALIMENTARYTRACT
`
`BASIC–
`
`Characterization of Mutant MUTYH Proteins Associated With Familial
`Colorectal Cancer
`
`MOHSIN ALI,*,‡,§,储 HYEJA KIM,* SEAN CLEARY,* CLAIRE CUPPLES,¶ STEVEN GALLINGER,* and ROBERT BRISTOW‡,§,储
`
`*Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; ‡Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret
`Hospital, University Health Network, Toronto, Ontario, Canada; §Department of Radiation Oncology, 储Department of Medical Biophysics, University of Toronto,
`Toronto, Ontario, Canada; and the ¶Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada
`
`Background & Aims: The human mutyh gene encodes
`a base excision repair protein that prevents G:C to T:A
`transversions in DNA. Biallelic mutations in this gene
`are associated with recessively inherited familial colo-
`rectal cancer. The aim of this study was to characterize
`the functional activity of mutant-MUTYH and single-
`nucleotide polymorphism (SNP)-MUTYH proteins in-
`volving familial colorectal cancer. Methods: MUTYH
`variants were cloned and assayed for their glycosylase
`and DNA binding activities using synthetic double-
`stranded oligonucleotide substrates by analyzing cleav-
`age products by polyacrylamide gel electrophoresis.
`Results: In this study, we have characterized 9 mis-
`sense/frameshift mutants and 2 SNPs for their DNA
`binding and repair activity in vitro. Two missense
`mutants (R260Q and G382D) were found to be
`partially active in both glycosylase and DNA bind-
`ing, whereas 3 other missense mutants (Y165C,
`R231H, and P281L) were severely defective in both
`activities. All of the frameshift mutants (Y90X, Q377X,
`E466X, and 1103delC) were completely devoid of both
`glycosylase and DNA binding activities. One SNP
`(V22M) showed the same activity as wild-type MUTYH
`protein, but the other SNP (Q324H) was partially im-
`paired in adenine removal. Conclusions: This study
`of MUTYH mutants suggests that certain SNPs may
`be as partially dysfunctional in base excision repair
`as missense-MUTYH mutants and lead to colorectal
`carcinogenesis.
`
`Endogenous reactive oxygen species (ROS) are pro-
`
`duced continually during normal cellular physiology
`owing to the production of metabolite by-products. ROS
`also are produced exogenously by either ionizing radia-
`tion or chemical carcinogens. ROS can cause a variety of
`DNA damage including double-strand breaks, single-
`strand breaks, and DNA base lesions1–3 such that the
`repair of ROS-induced DNA lesions is important for
`preventing mutations and maintaining the stability of
`the genome.
`One such ROS-induced base lesion is 8-hydroxy gua-
`nine (GO), which is generated from guanine (G) or de-
`oxyguanosine triphosphate and leads to G:C to T:A and
`
`T:A to G:C transversions, respectively.4,5 In human cells, 2
`base excision repair (BER) proteins, OGG1 and MUTYH,
`initiate the repair of GO lesions through their DNA
`glycosylase activity, whereas another protein, MTH1, hy-
`drolyses oxidized deoxyguanosine triphosphate. These
`glycosylase activities remove the damaged base and leave
`behind an apurinic/apyrimidinic site in the DNA. In
`subsequent processes, the long patch BER pathway com-
`pletes the repair process and this requires the APE1,
`PCNA, pol ␦(␧), FEN1, and DNA ligase I proteins.6 The
`OGG1, MTH1, and MUTYH enzymes work in concert:
`OGG1 removes GO from the DNA when paired with cytosine
`(C), whereas MTH1 prevents incorporation of GO in the DNA
`strand from the nucleotide pool by hydrolyzing 8-oxo-deox-
`yguanosine triphosphate to 8-oxo-deoxyguanosine mono-
`phosphate. If GO escapes from initial OGG1 action, DNA
`polymerase incorporates adenine (A) opposite to GO, allowing
`MUTYH to instead excise A from the A:GO pair, this
`allows for a secondary attempt by OGG1 to repair the
`GO lesion.7–9 MUTYH also can excise other DNA lesions
`including 8-hydroxadenine (from 8-hydroxyadenine:G)
`2-OH-A (from 2-OH-A:G) and A from A:G mispairs to a
`lesser extent.10 –14
`Recently, it was reported that germ-line mutations of
`the MUTYH gene are associated with familial colorectal
`cancer (CRC). While studying a British family affected
`with multiple colorectal polyposis, Al-Tassan et al15
`found 2 compound heterozygotes in the MUTYH gene
`in affected patients that substituted tyrosine at residue
`165 to cysteine, and glycine at residue 382 to aspartic
`acid. These investigators concluded that these somatic
`G:C to T:A transversions constitute a genetic signature
`of defective MUTYH protein activity in these CRC
`patients. Later, other groups confirmed the finding and
`concluded that
`in MUTYH-associated polyposis (ie,
`MAP), biallelic mutations of the MUTYH leading to G:C
`to T:A transversions in the adenomatous polyposis coli gene
`
`Abbreviations used in this paper: BER, base excision repair; CRC,
`colorectal cancer; GO, 8-hydroxyguanine; MAP, MUTYH-associated pol-
`yposis; ROS, reactive oxygen species; SNP, single-nucleotide polymor-
`phism; WT, wild type.
`
`© 2008 by the AGA Institute
`0016-5085/08/$34.00
`doi:10.1053/j.gastro.2008.04.035
`
`GDX 1034
`
`

`

`500 ALI ET AL
`
`GASTROENTEROLOGY Vol. 135, No. 2
`
`could drive colorectal epithelial cell genomic instability
`and increased cell proliferation in the epithelium of the
`colon.16 –24 To date, more than 80 mutations have been
`described in the MUTYH gene within MAP patients, with
`the Y165C and G382D variants as the most common
`documented mutations in Caucasian populations.25
`One method to study the function of CRC-associated
`MUTYH variant proteins mutations is to express them as
`recombinant proteins and assay for BER activity in vitro
`using synthetic DNA substrates containing A:GO and
`8-hydroxyadenine:G base mismatches. This has led to
`biochemical characterization of a number of CRC-related
`MUTYH variant proteins including Y165C, G382D,
`R227W, V232F, and R231L. For example, Al-Tassan et
`al15 showed that the Y82C and G253D MutY proteins of
`Escherichia coli (analogous to Y165C and G382D variants
`of human MUTYH, respectively) were partially defective
`in removing adenine from A:GO pairs. Wooden et al26
`reported that bacterially expressed recombinant Y165C
`and G382D MUTYH proteins were completely devoid of
`glycosylase activity. In another study, the R227W and
`V232F MUTYH mutants also were found to be partially
`or severely defective in both DNA substrate binding and
`glycosylase activity. Yet, the latter mutants still bound to
`hMutS␣ (a heterodimer of the human mismatch repair
`proteins hMSH2 and hMSH6 and a complex that can
`enhance MUTYH activity). In addition, both of these
`mutants failed to complement bacterial MutY deficiency
`when expressed in E coli cells in vivo.27
`Very recently, the R231L MUTYH mutant was shown to
`be severely defective in DNA substrate binding and in ade-
`nine removal activity. Although this variant showed intact
`binding activity with hMutS␣, it did not complement MutY
`deficiency in E coli.28 Parker et al10 reported that lysates
`derived from lymphoblastoid cell lines from MAP pa-
`tients who expressed the mutants Y165C, G382D, and
`1103delC had lowered DNA binding and adenine cleav-
`age.
`We recently completed a large multisite, population-
`based, CRC case-control study (Cleary et al, unpublished
`data) on a total of 3835 CRC cases and 2889 controls in
`which all subjects were screened for 9 known germline
`MUTYH mutations using mass spectrometry. DNA from
`subjects with at least one mutation was screened further
`by denaturing high performance chromatography/WAVE
`and sequencing analysis of WAVE variance. We found
`that 27 cases and 1 control subject carried either homozy-
`gous or compound heterozygous MUTYH mutations;
`carriers were at increased CRC risk (adjusted odds ratio,
`18.3; 95% confidence interval, 2.5–133.6). Heterozygous
`MUTYH mutations were identified in 88 CRC cases and
`44 controls; carriers were at increased risk of CRC (ad-
`justed odds ratio, 1.47; 95% confidence interval, 1.02–
`2.13).
`Herein, we have conducted an in vitro study of these
`clinically relevant MUTYH mutations as they directly re-
`
`late to human cancer risk. We selected 5 missense, 4
`nonsense or frameshift mutations, and 2 single-nucle-
`otide polymorphisms (SNPs) of MUTYH protein for in
`vitro characterization of their glycosylase and DNA bind-
`ing activities. We show that 2 frameshift mutants are
`partially active in DNA glycosylase and binding activities
`whereas the other 7 variants are totally devoid of both
`activities.
`
`Materials and Methods
`Construction of Vectors of N-Terminal
`Glutathione S-Transferase (GST)-Tagged
`MUTYH Proteins
`The MUTYH gene was amplified using polymerase
`chain reaction from a Hela cell complementary DNA library
`(Stratagene, La Jolla, CA) using the primers: 5=CATATTGAAT-
`TCATGACACCGCTCGTCTCC3= and 5=CATACGTCGACT-
`CACTGGGCTGCACTGTTGA3= with Phusion high-fidelity
`DNA polymerase (Invitrogen, Carlsbad, CA). Polyacrylamide
`gel electrophoresis (PAGE)-purified oligonucleotides were pur-
`chased from Operon (Huntsville, AL). Gel-purified products
`were digested with EcoRI and SalI restriction enzymes (Invitro-
`gen) and purified using nucleotide purification spin columns
`(Qiagen, Valencia, CA). The doubly digested products were
`ligated into the pGEX-4T-1 vector (GE Health Sciences, Pisca-
`taway, NJ) between EcoRI and SalI sites using T4 DNA ligase
`(Invitrogen). A final pGEX-4T-1-MUTYH (wild-type [WT])
`construct was transformed and grown in DH5␣ cells. Both
`strands of the extracted plasmid were sequenced for the entire
`open reading frame of the cloned MUTYH gene and the DNA
`sequences were confirmed to be the same as previously pub-
`lished sequences.7
`Mutations were generated in the cloned WT MUTYH
`gene in pGEX-4T-1 using a site-directed mutagenesis kit
`as per the manufacturer’s instructions (Promega, San
`Luis Obispo, CA). The base sequences on both strands of
`each mutant were confirmed by DNA sequence analysis.
`
`Protein Induction and Purification
`Expression vectors were transformed into the
`BL21 CodonPlus (Stratagene, La Jolla, CA) (DE3) RIL E
`coli strain. Cells were grown in luria broth medium with
`100 ␮g/mL of chloramphenicol and ampicillin at 37°C
`to 0.6 optical density at 600 nm and cooled on ice.
`Protein production was initiated by adding 0.4 mmol/L
`isopropyl-beta-D-thiogalactopyranoside (IPTG)
`to the
`cells and continuing incubation at room temperature for
`2 hours. Cells were harvested, washed with ice-cold phos-
`phate-buffered saline (PBS), and stored at ⫺80°C until
`protein purification.
`Cell pellets were resuspended into ice-cold PBS (1/40th
`of culture volume). Lysozyme (1 mg/mL), dithiothreitol
`(5 mmol/L), and protease inhibitor were added to the cell
`suspension and incubated on ice for 30 minutes followed
`by 3 freeze/thaw cycles and ultrasonic disruption. Cell
`lysates then were centrifuged at 15,000 rpm for 15 min-
`
`ALIMENTARY TRACT
`
`BASIC–
`
`GDX 1034
`
`

`

`August 2008
`
`CHARACTERIZATION OF MUTANT MUTYH 501
`
`ALIMENTARYTRACT
`
`BASIC–
`
`other bands in the lane in the scanned image by Image-
`Quant (GE Health Sciences) software (Figure 1A, lane 3, and
`supplementary Table 1; see supplementary material online
`at www.gastrojournal.org).
`
`MUTYH Glycosylase Assay
`A 5=-Cy5–labeled 39-mer oligonucleotide containing A
`at the 21-mer position from the 5=-end was hybridized with its
`complementary strand in a 100 ␮L buffer containing 20
`mmol/L Tris-HCl (pH 8), 10 mmol/L ethylenediaminetetraace-
`tic acid (EDTA) (pH 8), and 150 mmol/L NaCl to make the
`following duplex DNA substrate containing an A:GO mis-
`match:
`5=cyTGAGACTGGCCAGCTAACTGAACTGATCATGCCTAGCGT
`ACTCTGACCGGTCGATTGACXTGACTAGTACGGATCGCA,
`
`Where, X ⫽ GO.
`The glycosylase assay was performed according to the
`procedure used by Bai et al27 with slight modification.
`Briefly, 100 fmol 5=-Cy5–labeled duplex was incubated
`with 15 pmol wild-type or mutant MUTYH at 37°C for
`30 minutes in 10 ␮L buffer containing 50 mmol/L EDTA
`(pH 8), 500 ␮mol/L ZnCl2, 250 mmol/L HEPES (pH 7),
`and 1.5% glycerol. The reaction was stopped by adding 10
`␮L denaturing PAGE gel loading buffer containing 10
`mmol/L EDTA (pH 8), 98% formamide, 10 mg/mL blue
`dextran, and 200 mmol/L NaOH followed by heating at
`90°C for 30 minutes. Cleavage products were separated
`using a 14% denaturing PAGE gel running at 1400 V and
`100 W for 1 hour and fluorescent bands on the gel were
`visualized using a Typhoon Variable Imager (Amersham
`Biosciences, Piscataway, NJ). A schematic of this assay is
`shown in supplementary Figure 1A (see supplementary
`material online at www.gastrojournal.org). Enzymatic re-
`action rates were calculated at the 0–4 minute time points
`by linear regression.
`
`4™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
`Figure 1. Analysis of induction and purification of recombinant N-
`termini tagged GST-MUTYH mutant. (A) Cell lysates were resolved by a
`10% sodium dodecyl sulfate–PAGE followed by Coomassie-blue stain-
`ing to visualize expressed proteins. For each MUTYH protein: lane 1,
`lysate from uninduced cells; lane 2, lysate from IPTG-induced cells; lane
`3, partially purified GST-tagged protein. (B) Western blot analysis of
`purified recombinant GST-tagged MUTYH and its mutants using rabbit
`polyclonal antibody against MUTYH (C-termini–truncated variants
`Y90X, Q377X, E466X, and 1103delC were not detected because the
`antibody corresponded to amino acids 513-546 at the C-terminal of the
`MUTYH protein) or (C) mouse monoclonal antibody against GST. Fluor-
`conjugated secondary antibody bound to the antibody-antigen com-
`plex was detected by infrared image analyzer (LICOR, Lincoln, NE). (B
`and C) Lane assignment is as follows: lane 1, WT; lane 2, V22M; lane 3,
`D222N; lane 4, Q324H; lane 5, Y90X; lane 6, Q377X; lane 7, 1103delC;
`lane 8, Y165C; lane 9, R231H; lane 10, P281L; lane 11, R260Q; lane
`12, G382D; and lane 13, E466X; arrows indicate positions of the in-
`duced protein bands.
`
`utes and the clear supernatant was saved. A 50% slurry of
`glutathione sepharose beads (GE Health Sciences) was
`added to the clear lysate and rocked overnight at 4°C.
`Beads were pelleted by centrifugation at 2000 rpm for 5
`minutes and washed 4 times with ice-cold PBS. Finally,
`protein-bound beads were diluted with ice-cold PBS to
`make a 75% slurry. The concentrations of the partially
`purified proteins were estimated by the bicinchoninic acid
`method and proteins were stored at ⫺80°C until use. The
`purity of induced proteins was estimated by quantifying the
`band at the relevant molecular weight compared with all
`
`GDX 1034
`
`

`

`502 ALI ET AL
`
`GASTROENTEROLOGY Vol. 135, No. 2
`
`DNA Binding Assay
`For the DNA binding assay, GST-tag MUTYH
`proteins were eluted from the glutathione sepharose
`beads by an elution buffer containing 10 mmol/L re-
`duced glutathione and 50 mmol/L Tris-HCl, pH 8, and
`concentrated using a centrifugal filter (Millipore, Bed-
`ford, MA). A total of 100 fmol of Cy5-labeled 39-mer
`duplex DNA substrate containing A:GO base pair was
`incubated with 15 pmol partially purified, beads-free pro-
`teins at 37°C for 30 minutes in 18 ␮L buffer containing
`10 mmol/L Tris-HCl (pH 7.6), 0.5 mmol/L dithiothreitol,
`0.5 mmol/L EDTA, and 1.5% glycerol. The reaction mix-
`ture was supplemented with 2 ␮L of loading buffer (50%
`glycerol and 10 ␮g/␮L blue dextran) and analyzed by 6%
`nondenaturing PAGE gel
`in Tris-Borate-EDTA buffer
`running at 100 V at 4°C. The fluorescent bands on the
`gel were visualized using a Typhoon Variable Imager
`(Amersham Biosciences).
`
`Results
`Expression and Purification
`MUTYH is a human DNA glycosylase that re-
`moves A preferentially from A:GO pairs in DNA to pre-
`vent G:C to T:A transversions. In this study we charac-
`terized the adenine removal and DNA substrate binding
`activities of a series of MUTYH variants (ie, Y90X, Y165C,
`R231H, R260Q, P281L, Q377X, G382D, E466X, and
`1103delC), which are derived from MAP-phenotype pa-
`tients.
`Initially, we expressed these mutant proteins in vitro
`from a pTNT expression vector (Promega) using the TNT
`SP6 Quick Coupled Transcription/Translation system
`(Promega) and a significant amount of proteins were
`found to be induced. However, these proteins were found
`to be inactive. However, in subsequent studies using an in
`vivo approach, we were able to successfully induce N-
`termini GST-tag proteins from the pGEX-4T-1 expres-
`sion vectors in BL21 CodonPlus RIL E coli host cells and
`partially purify them with glutathione sepharose beads.
`We therefore expressed mutants and WT proteins, 2
`SNPs (V22M and Q324H), and enzyme-active center mu-
`tant (D222N) as a positive control, a pseudopositive
`control, and a negative control, respectively.
`The sodium dodecyl sulfate–PAGE analysis of the
`GST-tag recombinant MUTYH wild-type protein and its
`variants showed that the full-length (535 amino acid)
`proteins WT, V22M, D222N, Q324H, Y165C, R231H,
`R260Q, P281L, and G382D all had the expected and
`similar molecular weights based on the number of ex-
`pressed codons. The C-termini–truncated Y90X, Q377X,
`E466X, and 1103delC MUTYH mutant proteins were
`expressed as proteins with expected lower molecular
`weights of 37, 68, 78, and 70 kilodaltons, respectively.
`The specificity of protein induction was confirmed by
`
`Western blot analyses using polyclonal antibodies against
`MUTYH or GST (Figure 1).
`To ensure that the exogenous partially purified pro-
`teins were not contaminated with endogenous bacterial
`homolog MutY, we purified the WT, V22M, and D222N
`MUTYH proteins from uninduced and IPTG-induced
`cells and assayed their activities on duplex DNA sub-
`strates containing an A:GO mismatch. We observed
`that the proteins from uninduced cells harboring the plas-
`mids pGEX-4T-1-MUTYH (WT) and pGEX-4T-1-MUTYH
`(V22M) possessed slight adenine removal activity (compare
`lanes 4 and 6 in supplementary Figure 1B; see supplemen-
`tary material online at www.gastrojournal.org). This ac-
`tivity could be from the co-eluted bacterial MutY protein
`from the E coli host cells (ie, the BL21 CodonPlus RIL
`strain is not MutY-deficient) or from leaky MUTYH pro-
`tein. However, the D222N variant is an inactive protein
`because of a mutated enzyme-active site26 and it should
`not show any glycosylase activity. Indeed, the D222N
`variant partially purified from uninduced or IPTG-in-
`duced cells was found to be completely inactive (compare
`lanes 2 and 3 in supplementary Figure 1B; see supplemen-
`tary material online at www.gastrojournal.org). This sug-
`gests that the glycosylase activity detected in the unin-
`duced cells was from the leaky WT or V22M protein.
`Moreover, sodium dodecyl sulfate–PAGE analysis of the
`partially purified proteins did not show any band at 39
`kilodaltons that corresponded to the molecular weight of
`MutY. Therefore, we conclude that the N-termini GST-tag
`recombinant WT and mutant MUTYH proteins partially
`purified from the BL21 CodonPlus (DE3) RIL host cells
`are free from MutY contamination. This GST-tagged
`recombinant WT type MUTYH protein was almost as
`active as the standard bacterial homolog MutY protein.
`
`Adenine Removal Activity (Glycosylase
`Activity) Assay
`Figure 2 shows a typical in vitro glycosylase assay
`profile of wild-type or mutant MUTYH proteins on the
`synthetic duplex DNA substrates containing an A:GO
`pair. Similar to the bacterial homolog MutY control, the
`WT, V222M, and Q324H MUTYH proteins all were able to
`cleave substrates containing an A:GO mismatch (compare
`lanes C4, C5, and C6, respectively, with lane C3 in Figure 2).
`The major slower migrating band is a 20-mer ␣, ␤-unsat-
`urated aldehyde generated by ␤-elimination of
`the
`apurinic/apyrimidinic site by NaOH treatment. The mi-
`nor product migrating faster than the major product is a
`20-mer product with 5=-phosphate and produced from
`the ␤-elimination product by (cid:1)-elimination. Ohtsubo et
`al12 reported similar products from the substrates incu-
`bated with wild-type MUTYH.
`The intensity of the bands from the cleavage products
`generated by 2 missense MUTYH mutants (ie, R260Q
`and G382D) was much less compared with the bands
`from wild-type MUTYH protein (compare lanes C4 with
`
`ALIMENTARY TRACT
`
`BASIC–
`
`GDX 1034
`
`

`

`August 2008
`
`CHARACTERIZATION OF MUTANT MUTYH 503
`
`ALIMENTARYTRACT
`
`BASIC–
`
`Figure 2. Enzymatic activity of MUTYH mutants on 39-mer duplex DNA substrate containing A:GO mismatch. A total of 100 fmol 5=-Cy5–labeled
`duplex substrate was incubated with 15 pmol WT or mutants MUTYH at 37°C for 30 minutes and analyzed in a denaturing PAGE to detect cleavage
`products. Lane assignment is as follows: lane S, 20p-mer standard; lane C1, substrate only; lane C2, GST beads; lane C3, MutY (positive control);
`lane C4, WT (positive control); lane C5, V22M (pseudopositive control); C6, Q324H (pseudopositive control); C7, D222N (negative control); lane 1,
`Y90X; lane 2, Y165C; lane 3, R231H; lane 4, R260Q; lane 5, P281L; lane 6, Q377X; lane 7, G382D; lane 8, E466X; and lane 9, 1103delC.
`
`lanes 4 and 7 in Figure 2). The other missense mutants
`(Y165C, R231H, and P281L) and the frameshift mutants
`(Y90X, Q377X, E466X, and 1103delC) generated no
`products (Figure 2, lanes 1, 2, 3, 4, 5, 8, and 9) even after
`2 hours of incubation.
`The time-course assay of A:GO repair activity of WT and
`SNP-V22M MUTYH protein indicated that the generated
`products reached a maximum within 16 minutes and pla-
`teaued at periods of up to 180 minutes (Figure 3A). The rate
`constants k2 for SNP-Q324H MUTYH and WT were found
`to be 4.288 ⫾ 0.7831 min⫺1 and 4.507 ⫾ 0.5812 min⫺1,
`respectively (Figure 3B). We reproducibly detected only
`66% activity in the SNP-Q324H MUTYH compared with
`the WT at 2 minutes. The glycosylase activities of both
`missense mutants (R260Q and G382D) were 36% (k2 ⫽
`1.28 ⫾ 0.122 min⫺1) and 7% (k2 ⫽ 1.033 ⫾ 0.0979 min⫺1),
`respectively of the WI at 2 minutes (Figure 3). In contrast,
`the missense mutants (Y165C, R231H, and P281L) and
`frameshift mutants (Y90X, Q377X, E466X, and 1103delC)
`produced no products, even after 10 hours of incubation.
`
`DNA Binding Activity Assay
`The binding of repair proteins to DNA substrates
`is a crucial step in the repair process. Human cells recruit
`MUTYH protein to the A:GO site where it binds tightly
`to DNA and catalyzes the removal of A from A:GO
`mismatch. MUTYH and its bacterial homolog MutY re-
`main bound to the substrate even after removal of A,
`until displaced by other proteins that subsequently are
`recruited to complete the repair process. In this work, we
`also examined the effect of amino acid substitution in
`mutant MUTYH on DNA binding activity. Figure 4A
`shows a typical gel shift assay for wild-type and mutants
`of MUTYH.
`The WT and SNP MUTYH proteins formed 2 com-
`plexes with the duplex DNA substrates containing A:GO
`mismatch, whereas the MutY bacterial homolog formed
`only 1 complex (Figure 4A, lanes 2, 3, and 4). The sub-
`
`strates bound to WT MUTYH protein as complexes I and
`II were found to be 52% (26 fmol/pmol protein) and 22%
`(11 fmol/pmol protein), respectively. The missense mu-
`tants (R260Q and G382D) also formed complexes I and
`II with the DNA substrates. The DNA substrates bound
`to R260Q protein were estimated to be 18% (9 fmol/pmol
`protein) and 8% (4 fmol/pmol protein), respectively. On
`the other hand, 22% (11 fmol/pmol protein) and 14% (7
`fmol/pmol protein) substrates were bound with G382D
`as complexes I and II, respectively (Figure 4, lanes 9 and
`12). No such complexes were formed with the missense
`mutants (Y165C, R231H, and P281L) or with the frame-
`shift mutants (Y90X, Q377X, E466X, and 1103delC) (Fig-
`ure 4A, lanes 6 – 8, 10, 11, 13, and 14).
`
`Discussion
`Compound heterozygotes in the mutyh gene have
`been shown to be associated with familial CRC in human
`beings. In this work, we studied 9 bacterially expressed
`mutant MUTYH proteins for their DNA glycosylase and
`binding activities. In vitro assay using synthetic DNA
`substrates revealed that missense mutants (R260Q and
`G382D) are partially active in glycosylase activity (rate
`constants k2, 1.28 ⫾ 0.122 min⫺1 and 1.033 ⫾ 0.0979
`min⫺1, respectively, compared with 4.507 ⫾ 0.5812 min⫺1
`of WT) and DNA binding activity (26% and 36% of the
`substrates as complex I and II with R260Q and G382D,
`respectively) whereas mutants (Y90X, Y165C, R231H,
`P281L, Q377X, E466X, and 1103delC) are unable to
`generate any detectable cleavage products from the sub-
`strates containing A:GO mismatch or to bind to the
`substrates (Figures 2– 4).
`Previously, Al-Tassan et al15 showed that the E coli mu-
`tant Y82C (analog to human Y165C) shows barely detect-
`able glycosylase activity, whereas the mutant G253D (anal-
`ogous to the human G382D variant) cleaves adenine from
`an A:GO mismatch almost as efficiently as WT protein. And
`
`GDX 1034
`
`

`

`504 ALI ET AL
`
`GASTROENTEROLOGY Vol. 135, No. 2
`
`for the prediction of activity of clinical mutations in
`MUTYH based on sequence data.
`Importantly, our DNA binding results are consistent
`with the relative glycosylase activity of mutant MUTYH
`proteins. Frameshift mutants (Y90X, Q377X, E466X, and
`1103delC) were unable to remove A from the substrates
`(although they possess intact catalytic domains), proba-
`bly because of defective DNA-binding activity. Why the
`DNA-binding activity of the full-length (535 amino acid)
`missense MUTYH variants (Y165C, R231H, and P281L)
`was severely defective is unclear at this point and this
`deserves further study.
`We observed that despite similar substrate binding
`activity (74% and 68%, WT and Q324H, respectively), the
`SNP Q324H is only 66% active at 2 minutes in excising A
`(k2 ⫽ 2.971 ⫾ 0.2172 min⫺1) from the substrates com-
`pared with the WT (k2 ⫽ 4.507 ⫾ 0.5812 min⫺1). In
`contrast, Shinmura et al29 found Q324H to be fully active
`as WT. Interestingly, Yuan et al30 just reported that SNP
`Q324H is associated strongly with familial CRC among
`
`Figure 4. Binding of WT and mutant MUTYH proteins with DNA sub-
`strates containing an A:GO base pair. A total of 100 fmol of 5=-Cy5–
`labeled 39-mer substrates were incubated with 15 pmol partially puri-
`fied bead-free WT or mutant MUTYH proteins at 37°C for 30 minutes in
`binding buffer. (A) DNA-protein complexes were analyzed by 6% non-
`denaturing PAGE. Lane 1, substrate only; lane 2, MutY; lane 3, WT; lane
`4, Q324H; lane 5, D222N; lane 6, Y90X; lane 7, Y165C; lane 8, R231H;
`lane 9, R260Q; lane 10, P281L; lane 11, Q377X; lane 12, G382D; lane
`13, E466X; and lane 14, 1103delC. (B) DNA-protein complexes I and II
`were quantified by ImageQuant software. Product (mean ⫾ SD) of WT
`and mutant MUTYH was determined from 3 independent experiments.
`□, complex I; , complex II.
`
`Figure 3. Time-course activity of the mutant MUTYH proteins was
`assayed to compare their glycosylase activity with WT. A total of 1000
`fmol 5=-Cy5–labeled duplex was incubated with 150 pmol WT or mu-
`tant MUTYH in 100 ␮L buffer at 37°C, 10 ␮L was removed at 0, 1, 2, 4,
`8, 16, 32, 60, 120, and 180 minutes, and immediately stopped the
`reaction by adding 10 ␮L gel loading buffer with 200 mmol/L NaOH
`followed by heating at 90°C for 30 minutes. The reaction mix was
`fractionated and visualized by a Typhoon variable imager. (A) Major
`product I was quantified by ImageQuant software. Product (mean ⫾
`SD) of WT and mutant MUTYH were determined from 3 independent
`experiments. , WT; ‘, V22M; ’, Q324H; ⽧, R26OQ; ●, G382D; □,
`Y90X; ⌬, Y165C; , R231H; 〫, P281L; Œ, Q377X; ⫻, E466X; ⫹,
`1103⌬C. (B) Rate constants (mean ⫾ SD) were determined by linear
`regression.
`
`yet, in another study, the murine mutant G365D protein
`(also corresponding to the human G382D MUTYH variant)
`was found to be fully active in removing A from an A:GO
`pair.13 Wooden et al26 characterized bacterially expressed
`GST-tag mutants (Y165C and G382D) and found them
`completely devoid of glycosylase activity. When taken
`together, these previous data and our current data
`strongly suggest that frameshift mutants are completely
`defective in enzymatic activities because of loss of the
`C-terminal domain. Our study also shows that a muta-
`tion anywhere in the catalytic domain can impair enzyme
`activity (even at a distance from residue 222). This allows
`
`ALIMENTARY TRACT
`
`BASIC–
`
`GDX 1034
`
`

`

`August 2008
`
`CHARACTERIZATION OF MUTANT MUTYH 505
`
`Figure 5. Alignment of MUTYH
`and MutY amino acid se-
`quences. Unshaded, catalytic
`domain; shaded, C-terminal
`domain; red letter, conserved
`amino acid residue.
`
`ALIMENTARYTRACT
`
`BASIC–
`
`African Americans. Therefore, on the basis of our results,
`we concluded in addition to the germ-line mutations,
`SNPs also should be studied for their possible involve-
`ment in MAP.
`The MUTYH crystal structure has not yet been solved.
`However, the observed biochemical activity of the MUTYH
`variants in this study may be explained by the study of the
`amino acid sequence of the E coli MutY protein, which is
`41% identical with MUTYH.7,26 –28 MutY has a catalytic
`domain consisting of helix-hairpin-helix, pseudo helix-
`hairpin-helix and iron-sulfur cluster [4Fe-4S], and a char-
`acteristic C-terminal domain, which is not found in other
`helix-hairpin-helix-superfamily BER proteins.31–33
`Positions of the amino acid substitution of the mu-
`tants studied in this work are shown in Figure 5. All the
`missense mutants, except G382D, would lie within this
`catalytic domain. These amino acid residues are highly
`conserved among the human, E coli, murine, and Schizo-
`saccharomyces pombe MutY homologs. Although the C-
`terminal domain of E coli MutY protein is not needed for
`its adenine removal activity, it strongly interacts with the
`GO-containing strand to flip the target adenine out of
`the helix. In this way, A is buried into a pocket formed
`between the 6-helix barrel module and the [4Fe-4S] mod-
`ule and subsequently the ␤-glycosidic bond between A
`and pentose sugar moiety is hydrolyzed by the protein’s
`glycosylase activity.31,32 The mutation in the G382D vari-
`ant lies within the C-terminal domain, which is required
`for GO recognition. In support of this theory, it has been
`shown previously that the removal of this domain from
`MutY protein drastically reduces its adenine incision
`activity from A:GO pair, but not from A:G mismatch.33
`Therefore, the inactivity of our frameshift variants can be
`explained by the fact that the Y90X mutant loses both
`catalytic domain and the C-terminal domain whereas the
`other mutants (Q377X, E466X, and 1103delC) lost only
`the catalytic domain (Figure 5). Indeed, it was previously
`
`shown that the C-terminal domain truncated MutY is
`not only defective in removing A, but also in binding
`substrate containing A:GO.33,34
`A mutation in the catalytic domain might render the
`protein partially or fully inactive whereas the loss of
`C-terminal domain could impair binding to the substrate
`containing A:GO. Protein products of SNPs are generally
`active as WT, but we observed that the SNP Q324H is
`34% less active than WT. This finding is consistent
`with the recent observation by Yuan et al,30 who re-
`ported that the Q342H variant SNP is associated
`strongly with familial CRC among the African-Ameri-
`can population. The second SNP V22M was found
`to be as active as the WT (k2 ⫽ 4.288 ⫾ 0.7831 and
`4.507 ⫾ 0.5812 min⫺1, respectively). In summary, we
`have characterized in vitro a large series of frameshift,
`missense mutants, and SNP of MUTYH in one labora-
`tory setting that are associated clinically with increased
`CRC risk. The results are summarized in Table 1. The
`2 missense variants (R260Q and G382D) were partially
`active in DNA binding and BER activities, whereas 3
`missense variants (Y165C, R231H, and P281L) and all 4
`frameshift variants (Y90X Q377X, E466X, and 1103delC)
`were dysfunctional in both activities.
`Adding further complexity is that there may be cross-
`talk between repair pathways in preventing colorectal
`carcinogenesis. In human cells, 3 BER proteins (OGG1,
`MTH1, and MUTYH) and 3 MMR proteins (MSH2,
`MSH6, and MLH1) guard genomes from mutagenic
`DNA base lesion 8-oxoG.35 Their functions have been
`well studied both in vitro and in vivo and indeed MMR
`and MUTYH proteins interact biochemically.12,13,29,36 – 40
`As such, mutations in the MUTYH catalytic domain that
`render the protein fully or partially inactive could abro-
`gate normal interactions between MUTYH and MMR
`proteins. In this study, we further confirmed that even
`mutations outside the catalytic domain can deactivate
`
`GDX 1034
`
`

`

`506 ALI ET AL
`
`GASTROENTEROLOGY Vol. 135, No. 2
`
`Table 1. Summary of Activities of WT and Variant MUTYH Proteins
`
`Mutant
`
`Y90X
`Q377X
`E466X
`1103⌬C
`R260Q
`G382D
`Y165C
`R231H
`P281L
`Q324H
`V22M
`WT
`
`Type of mutation
`
`Glycosylase activity
`
`DNA binding activity
`
`Frameshift
`Frameshift
`Frameshift
`Frameshift
`Missense
`Missense
`Missense
`Missense
`Missense
`SNP
`SNP
`
`Severely defective
`Severely defective
`Severely defective
`Severely defective
`Partial (k2 ⫽ 1.28 ⫾ 0.12 min⫺1)
`Partial (k2 ⫽ 1.033 ⫾ 0.098 min⫺1)
`Severely defective
`Severely defective
`Severely defective
`Partial (k2 ⫽ 2.97 ⫾ 0.22 min

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket